Voltar
Artigo Acesso aberto Produção Nacional Revisado por pares
BIBTEX RIS

Effectiveness and Safety of Direct-Acting Antivirals in the Treatment of Chronic Hepatitis C: A Real-life Study in Northeastern Brazil

2024; Brazilian Society of Tropical Medicine; Volume: 57; Linguagem: Inglês

10.1590/0037-8682-0192-2024

ISSN

1678-9849

Autores

Elodie Bomfim Hyppólito, Alberto Novaes Ramos, Larissa Peixoto Teixeira, Antônia Marques Grangeiro Bezerra, Lucille Mendes, Taynara Laís Silva, José Milton de Castro Lima, Érico Antônio Gomes de Arruda, E. Guerra, Maria Macedo Saraiva Tavares, Carlos Eduardo Pereira Lima, Ticiana Mota Esmeraldo, Francisco Sérgio Rangel de Paula Pessoa, Alessandra Maria Mont`Alverne Pierre, Karla Brandão Pereira, Antônio Haroldo Araújo Filho, Lívia Melo Carone Linhares, Anderson Fuentes Ferreira, Roberto da Justa Pires Neto,

Tópico(s)

Liver Disease Diagnosis and Treatment

Resumo

This study aimed to evaluate the effectiveness and safety of direct-acting antivirals (DAAs) for hepatitis C treatment by measuring sustained virologic response (SVR) and serious adverse events to help design effective interventions for reducing disease prevalence.

Referência(s)